288 related articles for article (PubMed ID: 36803866)
1. A head-to-head comparison of the EQ-5D-5L and 15D descriptive systems and index values in a general population sample.
Nikl A; Janssen MF; Brodszky V; Rencz F
Health Qual Life Outcomes; 2023 Feb; 21(1):17. PubMed ID: 36803866
[TBL] [Abstract][Full Text] [Related]
2. A Direct Comparison of the Measurement Properties of EQ-5D-5L, PROMIS-29+2 and PROMIS Global Health Instruments and EQ-5D-5L and PROPr Utilities in a General Population Sample.
Rencz F; Brodszky V; Janssen MF
Value Health; 2023 Jul; 26(7):1045-1056. PubMed ID: 36804583
[TBL] [Abstract][Full Text] [Related]
3. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis.
Koszorú K; Hajdu K; Brodszky V; Bató A; Gergely LH; Kovács A; Beretzky Z; Sárdy M; Szegedi A; Rencz F
Eur J Health Econ; 2023 Feb; 24(1):139-152. PubMed ID: 35412162
[TBL] [Abstract][Full Text] [Related]
4. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
Jankowska A; Młyńczak K; Golicki D
Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
[TBL] [Abstract][Full Text] [Related]
5. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey.
Xie S; Wang D; Wu J; Liu C; Jiang W
Health Qual Life Outcomes; 2022 Jun; 20(1):96. PubMed ID: 35710429
[TBL] [Abstract][Full Text] [Related]
7. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
[TBL] [Abstract][Full Text] [Related]
8. Danish population health measured by the EQ-5D-5L.
Jensen MB; Jensen CE; Gudex C; Pedersen KM; Sørensen SS; Ehlers LH
Scand J Public Health; 2023 Mar; 51(2):241-249. PubMed ID: 34847818
[TBL] [Abstract][Full Text] [Related]
9. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
10. The added value of extending the EQ-5D-5L with an itching item for the assessment of health-related quality of life of burn patients: an explorative study.
Spronk I; Bonsel GJ; Polinder S; van Baar ME; Janssen MF; Haagsma JA
Burns; 2021 Jun; 47(4):873-879. PubMed ID: 33012569
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Psychometric Properties of the EQ-5D-3L-Y and EQ-5D-5L-Y Instruments in Spanish Children and Adolescents.
Pérez-Sousa MÁ; Olivares PR; Ramírez-Vélez R; Gusi N
Value Health; 2021 Dec; 24(12):1799-1806. PubMed ID: 34838278
[TBL] [Abstract][Full Text] [Related]
12. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
Yfantopoulos J; Chantzaras A; Kontodimas S
Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
[TBL] [Abstract][Full Text] [Related]
14. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
Pattanaphesaj J; Thavorncharoensap M
Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
[TBL] [Abstract][Full Text] [Related]
15. Validity of EQ-5D-5L in stroke.
Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
[TBL] [Abstract][Full Text] [Related]
16. Testing the Psychometric Properties of 9 Bolt-Ons for the EQ-5D-5L in a General Population Sample.
Rencz F; Janssen MF
Value Health; 2024 Apr; ():. PubMed ID: 38599517
[TBL] [Abstract][Full Text] [Related]
17. The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.
Bató A; Brodszky V; Gergely LH; Gáspár K; Wikonkál N; Kinyó Á; Szabó Á; Beretzky Z; Szegedi A; Remenyik É; Kiss N; Sárdy M; Rencz F
Qual Life Res; 2021 May; 30(5):1477-1490. PubMed ID: 33534032
[TBL] [Abstract][Full Text] [Related]
18. A Comparison of a Preliminary Version of the EQ-HWB Short and the 5-Level Version EQ-5D.
Monteiro AL; Kuharic M; Pickard AS
Value Health; 2022 Apr; 25(4):534-543. PubMed ID: 35279371
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population.
Kangwanrattanakul K; Parmontree P
Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315
[TBL] [Abstract][Full Text] [Related]
20. Validity of the EQ-5D-5L questionnaire among the general population of Poland.
Młyńczak K; Golicki D
Qual Life Res; 2021 Mar; 30(3):817-829. PubMed ID: 33099710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
